Transfer Of Value Disclosure

FINANCIAL INFORMATION:

The following describes the funding received from non-NHS organisations to support programmes of work that aim to improve the health and care system in  the North East and North Cumbria:

Organisations Involved Start Date End Date Monetary Value Reason for Benefit
Chiesi Farmaceutici and AHSN NENC 01/02/2022 05/16/2022 £5,000.00 To develop the Pharm outcomes template for the Tees Valley Inhaler Project
OrionPharma (UK) Ltd and AHSN NENC 01/02/2022 05/16/2022 £5,400.00 To develop the Pharm outcomes template for the Tees Valley Inhaler Project
AstraZeneca PLC and AHSN NENC 01/02/2022 05/16/2022 £26,400.00 To deliver the pilot programme of work for the Tees Valley Inhaler project
GlaxoSmithKline and AHSN NENC 01/02/2022 05/16/2022 £5,400.00 To develop the Pharm outcomes template as part of the Tees Valley Inhaler project
Abbott and AHSN NENC 06/01/2022 05/31/2023 £25,000.00 To undertake a Real World Evaluation
Sanofi 31/03/2022 30/09/2023 £37,479.28 JWA to facilitate earlier diagnosis of Fabry, Pompe and Gaucher diseases through the use of disease prediction models using real-work data from Primary Care records (CDRC – rare diseases)